Department of Anesthesiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States of America.
Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Pharmacol Ther. 2021 Sep;225:107843. doi: 10.1016/j.pharmthera.2021.107843. Epub 2021 Mar 31.
COVID-19 has remained an uncontained, worldwide pandemic. While battling for the disease in China, six Traditional Chinese Medicine (TCM) recipes have been shown to be remarkably effective for treating patients with COVID-19. The present review discusses principles of TCM in curing infectious disease, and clinical evidence and mechanisms of the 6 most effective TCM recipes used in treating COVID-19 in 92% of all of the confirmed cases in China. Applications of TCM and specific recipes in the treatment of other viral infections, such as those caused by SARS-CoV, MERS-CoV, hepatitis B virus, hepatitis C virus, influenza A virus (including H1N1 and H7N9), influenza B, dengue virus as well as Ebola virus, are also discussed. Among the 6 TCM recipes, Jinhua Qinggan (JHQG) granules and Lianhua Qingwen (LHQW) capsules are recommended during medical observation; Lung Cleansing and Detoxifying Decoction (LCDD) is recommended for the treatment of both severe and non-severe patients; Xuanfeibaidu (XFBD) granules are recommended for treating moderate cases; while Huashibaidu (HSBD) and Xuebijing (XBJ) have been used in managing severe cases effectively. The common components and the active ingredients of the six TCM recipes have been summarized to reveal most promising drug candidates. The potential molecular mechanisms of the active ingredients in the six TCM recipes that target ACE2, 3CL and IL-6, revealed by molecular biological studies and/or network pharmacology prediction/molecular docking analysis/visualization analysis, are fully discussed. Therefore, further investigation of these TCM recipes may be of high translational value in enabling novel targeted therapies for COVID-19, potentially via purification and characterization of the active ingredients in the effective TCM recipes.
新冠病毒疫情仍在全球蔓延。在中国抗击疫情的过程中,有 6 个中医药方剂被证明对治疗新冠肺炎患者具有显著疗效。本综述讨论了中医药治疗传染病的原则,以及在中国确诊的 92%的新冠肺炎患者中,6 个最有效的中医药方剂治疗新冠肺炎的临床证据和作用机制。还讨论了中医药在治疗其他病毒感染,如 SARS-CoV、MERS-CoV、乙型肝炎病毒、丙型肝炎病毒、甲型流感病毒(包括 H1N1 和 H7N9)、乙型流感病毒、登革热病毒以及埃博拉病毒方面的应用,以及特定方剂的应用。在这 6 个中医药方剂中,金花清感颗粒和连花清瘟胶囊被推荐用于医学观察;清肺排毒汤被推荐用于治疗重症和非重症患者;宣肺败毒颗粒被推荐用于治疗中度病例;而化湿败毒颗粒和血必净已被有效用于治疗重症病例。总结了这 6 个中医药方剂的共同成分和有效成分,以揭示最有前途的候选药物。通过分子生物学研究和/或网络药理学预测/分子对接分析/可视化分析,充分讨论了这些中医药方剂中针对 ACE2、3CL 和 IL-6 的有效成分的潜在分子机制。因此,对这些中医药方剂的进一步研究可能具有很高的转化价值,可通过对有效中医药方剂中有效成分的纯化和表征,为新冠肺炎提供新的靶向治疗方法。